England's NICE is recommending natalizumab, sold as Tysabri and Tyruko, as an NHS-covered treatment option for people with highly active RRMS.

The Elliot's Neurological Specialties clinic combines medical treatments to slow MS progression with holistic approaches to ...

Monoclonal antibody DMTs, especially anti-CD20 therapies, effectively prevent relapses but have limited impact on progressive MS. Progressive MS involves compartmentalized CNS inflammation, with ...

How fast can your team pull a 7,500-pound tractor 20 yards? On June 1, the National Multiple Sclerosis (MS) Society, New Jersey Metro chapter will welcome teams of up to six people to Pull for a Cure ...